Endeavor

Moffitt Aims to Improve CAR T Therapy

The cancer center is leading several trials to improve delivery and effectiveness of the cellular immunotherapy

Jeff Bridges Announces Lymphoma Diagnosis

Remission is possible, depending on the cancer’s biology

Is Your Rash a Cold, the Flu or Lymphoma?

Here’s when itchy skin may be a sign of cancer

Speeding Up Cellular Immunotherapy

New ‘off the shelf’ CAR T product shows promise in phase 1 study

Bridging Therapy Not Recommended for All CAR T Patients

New data presented by Moffitt shows poorer outcome for patients who receive bridging therapy prior to CAR T-cell therapy.

Together We Will (Fight Cancer)

Alexandra Buchanan started a Miles for Moffitt team last year while her dad was in treatment for non-Hodgkin lymphoma

Do You Know Your Lymphomas?

Lymphoma comes in different types and the most recognizable forms tend to include the name Hodgkin.

The Pride of St. Pete

Non-Hodgkin lymphoma survivor gives back to community.

You’ve been diagnosed with Non-Hodgkin Lymphoma. Now What?

A panel of experts will address patient concerns Aug. 8